Sunday, 26 October 2014

News

Basilea appoints Ronald Scott as CEO to succeed Anthony Man and expands ...

10 Dec 2012 21:06Equities.com
Basilea Pharmaceutica Ltd. is headquartered in Basel, Switzerland, and listed on the SIX Swiss Exchange (SIX: BSLN). Through the fully integrated research and development operations of its Swiss subsidiary Basilea Pharmaceutica International Ltd.